Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Ischemic Brain Damage and Single Quantum Sodium MRI
Coalition for Placer Youth - DFC Support Program 2009
Systematics and Evolution of Nematode Family Rhabditidae
Maintenance of a Database of Research Ship Schedules
Conference on the Biology of Nematocysts; August 24-29, l986; Irvine, California
Recently added grants:
Cancer Center Support Grant
The role of CMTR2 in Lung Cancer
Metabolically active macrophages: a novel link between obesity and triple negative breast cancer
The Role of Stem Cells and the Microenvironment in Gastrointestinal Cancers
Pre-BCR and STAT5 Signaling in Acute Lymphoblastic Leukemia
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB67190-2-0-1
Application #
7574870
Study Section
Project Start
2006-09-30
Project End
2009-12-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/ Albert Einstein College of Medicine
$396,788
NIH 2007
N01 HL
Sildenafil for Sickle Cell Disease-Associated Pulmonary Hypertension
Little, Jane /
$471,185
NIH 2007
N01 HL
Phase II/III Trial-Sildenafil for Sickle Cell Disease-Assoc. Pulm. Hypertension
/
NIH 2007
N01 HL
/
Comments
Be the first to comment on this grant